ACELRX PHARMACEUTICALS INC - FORM 10-Q - EX-10.5 - EXHIBIT 10.5

Attached files

file	filename
10-Q - FORM 10-Q - ACELRX PHARMACEUTICALS INC	acrx20160201_10q.htm
EX-32.1 - EXHIBIT 32.1 - ACELRX PHARMACEUTICALS INC	ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - ACELRX PHARMACEUTICALS INC	ex31-2.htm
EX-10.6 - EXHIBIT 10.6 - ACELRX PHARMACEUTICALS INC	ex10-6.htm
EX-10.3 - EXHIBIT 10.3 - ACELRX PHARMACEUTICALS INC	ex10-3.htm
EX-10.4 - EXHIBIT 10.4 - ACELRX PHARMACEUTICALS INC	ex10-4.htm
EX-31.1 - EXHIBIT 31.1 - ACELRX PHARMACEUTICALS INC	ex31-1.htm

W81XWH-15-C-0046

P00005

Page 2 of 2

SECTION SF 30 BLOCK 14 CONTINUATION PAGE

SUMMARY OF CHANGES

SECTION A - SOLICITATION/CONTRACT FORM

The following have been modified:

ADDITIONAL INFORMATION

The Contractor’s final proposal dated 13 February 2015 is herein incorporated by reference.

The Contractor’s final proposal (for LRIP option) dated 16 April 2015 is herein incorporated by reference.

March 2016 (Mod P00005): The ARX-04 clinical program had to be revised based on the outcome of the Contractor’s pre-New Drug Application (NDA) meeting with the U. S. Food and Drug Administration (FDA). The Contractor’s Issue Summary Report (ISR), dated 14 January 2016, is herein incorporated by reference.

Government Property:

No Government-furnished property will be used in the performance of this contract.

No Contractor-acquired, Government-owned property will be purchased for this contract.

All equipment used in the performance of this contract (except where subcontractors are utilized) will be purchased by AcelRx using their own funds.

SECTION F - DELIVERIES OR PERFORMANCE

The following Delivery Schedule item for CLIN 0001 has been changed from:

DELIVERY DATE

QUANTITY

SHIP TO ADDRESS

DODAAC

POP 11-MAY-2015 TO

10-NOV-2016

N/A

FORT DETRICK-USAMMDA

1430 FORT DETRICK

FREDERICK MD 21702

FOB: Destination

W806YH

To: